Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol versus ondansetron for emergency department nausea
ACTRN12619001205123Phase 4Completed
- Sponsor
- A/Prof Gabriel T Lau
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in nausea ((none)) and Vomiting comparing Droperidol IV with Ondansetron IV (2 arms). Started Feb 2020; status: completed.
02
Drugs
droperidolondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on ACTRN12619001205123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001205123.